Search Results - "BUNCH, Roderick T"

Refine Results
  1. 1

    Acute Molecular Markers of Rodent Hepatic Carcinogenesis Identified by Transcription Profiling by Kramer, Jeffrey A, Curtiss, Sandra W, Kolaja, Kyle L, Alden, Carl L, Blomme, Eric A. G, Curtiss, William C, Davila, Julio C, Jackson, Carmen J, Bunch, Roderick T

    Published in Chemical research in toxicology (01-04-2004)
    “…Currently, the only way to identify nongenotoxic hepatocarcinogens is through long-term repeat dose studies such as the 2 year rodent carcinogenicity assay…”
    Get full text
    Journal Article
  2. 2

    MicroRNA as biomarkers of mitochondrial toxicity by Baumgart, Bethany R., Gray, Katherine L., Woicke, Jochen, Bunch, Roderick T., Sanderson, Thomas P., Van Vleet, Terry R.

    Published in Toxicology and applied pharmacology (01-12-2016)
    “…Mitochondrial toxicity can be difficult to detect as most cells can tolerate reduced activity as long as minimal capacity for function is maintained. However,…”
    Get full text
    Journal Article
  3. 3
  4. 4

    Allogeneic murine pregnancy models for assessing the developmental effects of immune‐stimulating antibodies: Challenges in reproducibility by Thompson, Kary E., Danberry, Tracy L., Bunch, Roderick T., Graziano, Michael J., McNerney, Mary E.

    Published in Birth defects research (01-10-2019)
    “…Literature suggests that murine allogeneic pregnancy models are an alternative approach for evaluating the developmental toxicity of immune‐stimulating agents…”
    Get full text
    Journal Article
  5. 5

    d-α-tocopheryl polyethylene glycol 1000 succinate-containing vehicles provide no detectable chemoprotection from oxidative damage by Baumgart, Bethany R., Van Vleet, Terry R., Simic, Damir, Salcedo, Theodora W., Lentz, Kimberley, Donegan, Michael, Davies, Marc H., Bunch, Roderick T., Sanderson, Thomas P., Lange, Robert W.

    Published in Journal of applied toxicology (01-07-2015)
    “…The objective of this study was to evaluate potential protective effects of vehicles containing d‐α‐tocopheryl polyethylene glycol 1000 succinate (TPGS), which…”
    Get full text
    Journal Article
  6. 6

    The Pathologist and Toxicologist in Pharmaceutical Product Discovery by Alden, Carl L., Sagartz, John E., Smith, Peter F., Wilson, Alan G., Bunch, Roderick T., Morris, Dale L.

    Published in Toxicologic pathology (01-01-1999)
    “…Significant change is occurring in the drug discovery paradigm; many companies are utilizing dedicated groups from the toxicology/ pathology disciplines to…”
    Get full text
    Journal Article Conference Proceeding
  7. 7

    Interspecies differences in renal localization of cyclooxygenase isoforms: implications in nonsteroidal antiinflammatory drug-related nephrotoxicity by Khan, K N, Venturini, C M, Bunch, R T, Brassard, J A, Koki, A T, Morris, D L, Trump, B F, Maziasz, T J, Alden, C L

    Published in Toxicologic pathology (01-09-1998)
    “…Cyclooxygenase (COX) exists in 2 related but unique isoforms: one is constitutive (COX-1) and functions in normal cell physiology, and the other is inducible…”
    Get more information
    Journal Article
  8. 8

    Transcription profiling distinguishes dose-dependent effects in the livers of rats treated with clofibrate by KRAMER, Jeffrey A, BLOMME, Eric A. G, BUNCH, Roderick T, DAVILA, Julio C, JACKSON, Carmen J, JONES, Patrick F, KOLAJA, Kyle L, CURTISS, Sandra W

    Published in Toxicologic pathology (01-07-2003)
    “…Peroxisome proliferators such as the fibrates act via the peroxisome proliferator activated receptor (PPAR)-alpha as hypolipidemic agents. Many peroxisome…”
    Get full text
    Journal Article
  9. 9
  10. 10
  11. 11

    Revolution through Genomics in Investigative and Discovery Toxicology by Rodi, Charles P., Bunch, Roderick T., Curtiss, Sandra W., Kier, Larry D., Cabonce, Marc A., Davila, Julio C., Mitchell, Michael D., Alden, Carl L., Morris, Dale L.

    Published in Toxicologic pathology (01-01-1999)
    “…The remarkable technologic and methodologic advances spurred on by the Human Genome Project are being applied throughout the life sciences. In the field of…”
    Get full text
    Journal Article Conference Proceeding
  12. 12

    d-[alpha]-tocopheryl polyethylene glycol 1000 succinate-containing vehicles provide no detectable chemoprotection from oxidative damage by Baumgart, Bethany R, Van Vleet, Terry R, Simic, Damir, Salcedo, Theodora W, Lentz, Kimberley, Donegan, Michael, Davies, Marc H, Bunch, Roderick T, Sanderson, Thomas P, Lange, Robert W

    Published in Journal of applied toxicology (01-07-2015)
    “…The objective of this study was to evaluate potential protective effects of vehicles containing d-[alpha]-tocopheryl polyethylene glycol 1000 succinate (TPGS),…”
    Get full text
    Journal Article
  13. 13
  14. 14

    Enhancement of cisplatin-induced cytotoxicity by 7-hydroxystaurosporine (UCN-01), a new G2-checkpoint inhibitor by BUNCH, R. T, EASTMAN, A

    Published in Clinical cancer research (01-05-1996)
    “…DNA-damaging agents arrest cell cycle progression at either G1 or G2. A variety of agents such as caffeine have been shown to abrogate the DNA damage-dependent…”
    Get full text
    Journal Article
  15. 15

    Transcription Profiling Distinguishes Dose-Dependent Effects in the Livers of Rats Treated with Clofibrate by Kramer, Jeffrey A., Blomme, Eric A.G., Bunch, Roderick T., Davila, Julio C., Jackson, Carmen J., Jones, Patrick F., Kolaja, Kyle L., Curtiss, Sandra W.

    Published in Toxicologic pathology (01-06-2003)
    “…Peroxisome proliferators such as the fibrates act via the peroxisome proliferator activated receptor (PPAR)-α as hypolipidemic agents. Many peroxisome…”
    Get full text
    Journal Article
  16. 16

    Phenobarbital does not promote hepatic tumorigenesis in a twenty-six-week bioassay in p53 heterozygous mice by Sagartz, J E, Curtiss, S W, Bunch, R T, Davila, J C, Morris, D L, Alden, C L

    Published in Toxicologic pathology (01-07-1998)
    “…The tumorigenic potential of phenobarbital was examined in a 26-wk carcinogenesis bioassay using p53 heterozygous mice and wild-type controls. Fifteen…”
    Get more information
    Journal Article
  17. 17

    Influence of amsacrine (m-AMSA) on bulk and gene-specific DNA damage and c-myc expression in MCF-7 breast tumor cells by Bunch, R T, Povirk, L F, Orr, M S, Randolph, J K, Fornari, F A, Gewirtz, D A

    Published in Biochemical pharmacology (20-01-1994)
    “…In the MCF-7 human breast tumor cell line, the aminoacridine, m-AMSA, induces protein-associated DNA strand breaks consistent with inhibition of topoisomerase…”
    Get more information
    Journal Article
  18. 18

    Selective damage to the active X chromosome by camptothecin and amsacrine as determined by an allele-specific alkaline unwinding assay by Austin, M.J.Finley, Bunch, Roderick T., Povirk, Lawrence F.

    Published in Biochemical pharmacology (12-10-1995)
    “…Previous studies with MCF-7 cells demonstrated that several agents induce greater strand breakage in active genes than in nontranscribed centromeric regions…”
    Get full text
    Journal Article
  19. 19

    7-Hydroxystaurosporine (UCN-01) causes redistribution of proliferating cell nuclear antigen and abrogates cisplatin-induced S-phase arrest in Chinese hamster ovary cells by BUNCH, R. T, EASTMAN, A

    Published in Cell growth & differentiation (01-07-1997)
    “…A variety of agents, such as caffeine, have been shown to abrogate the DNA damage-dependent G2 checkpoint and enhance cytotoxicity. However, these agents are…”
    Get full text
    Journal Article
  20. 20

    Components of intrinsic drug resistance in the rat hepatoma by Ellis, A L, Munger, C E, Bunch, R T, Woods, K E, Randolph, J K, Boise, L, Swerdlow, P S, Zwelling, L A, Hinds, M, Yanovich, S

    Published in Biochemical pharmacology (22-01-1992)
    “…A carcinogen-transformed rat hepatoma cell line (Reuber H-35) was utilized as a model system for investigation of the biochemical factors which may limit the…”
    Get more information
    Journal Article